WARRANT AGENT AGREEMENTWarrant Agent Agreement • May 12th, 2015 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Warrant Agent Agreement made as of May __, 2015, is between DelMar Pharmaceuticals, Inc. a Nevada corporation, with offices at 720-999 West Broadway, Vancouver, British Columbia, Canada V5Z1K5 (the “Company”), and Island Stock Transfer with offices at 15500 Roosevelt Blvd, Suite 301, Clearwater Florida 33760 (the “Warrant Agent”).
Class B Warrants to Purchase One Share of Common StockUnderwriting Agreement • May 12th, 2015 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
DelMar Pharmaceuticals, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named on Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Maxim Group LLC and Roth Capital Partners, LLC are acting as joint bookrunning managers (in such capacity, together the “Joint Bookrunners” and each, a “Joint Bookrunner”) and National Securities Corporation is acting as co-manager an aggregate of [____] shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company and [___] class A warrants (the “Class A Warrants”) and [____] class B warrants (the “Class B Warrant” and collectively, with the Class A Warrants, the “Firm Warrants”), each Class A Warrant entitles the holder to purchase one share of Common Stock at an exercise price of $[____] per share at any time prior to the expiration thereof on [____] and each Class B Warrant entitle
